Tag: technology

news-27112024-175935

Biotech News Roundup: Stay Updated on the Latest Developments in the Industry

Good morning, everyone! Today, we have some interesting updates from the biotech industry. The BIOSECURE Act is facing a crucial moment as it needs to be passed by Congress by December to avoid obstacles,...
news-07112024-155051

Biotech Outlook Post-Trump Presidency: What’s Next?

Adam: Hey Matt, glad you could join me today. The future of the biotech industry post-Trump presidency is something that many are curious about. One key aspect that everyone is keeping an eye on...
news-15112024-162349

CAR-T Therapy Shows Promise in Treating Aggressive Brain Tumors in Young Patients

Michelle Monje-Deisseroth, a medical student about 20 years ago, treated patients with a type of brain tumor called diffuse intrinsic pontine gliomas, or DIPG. These tumors are difficult to treat because they wrap around...
news-14112024-161449

Merck Expands Portfolio with Licensing of Chinese Cancer Drug

Merck, a leading pharmaceutical company, has recently taken a strategic step to enhance its cancer drug portfolio by acquiring the licensing rights for a new cancer drug from LaNova Medicines, a Chinese firm based...
news-11112024-034923

FDA Plans to Ban Cold Medicine, Eisai’s Alzheimer’s Drug Sales, and More: Pharmalittle Update

As we approach the end of another workweek, it's time to start thinking about weekend plans. Our schedule includes tending to the Pharmalot grounds, spending time with our beloved mascots, and catching up on...
news-12112024-041658

Ending 23andMe’s Drug Discovery Dream: What Went Wrong?

23andMe, the genetics company that many people have been excited about, recently made a big announcement. The company has decided to stop working on creating new medicines and will be letting go of 40%...
news-17102024-144107

Maximizing Claim Denials: How Medicare Advantage Insurers Utilize Technology to Deny Claims

A recent Senate investigation revealed that the three largest Medicare Advantage insurers in the nation, including UnitedHealth Group, Humana, and CVS Health, have been increasingly denying claims for rehabilitative care for seniors. This denial...
news-29112024-062000

AI Drug Development Company Recursion Cuts Jobs Post Exscientia Merger

Recursion Pharmaceuticals, a company known for its innovative use of artificial intelligence and machine learning in drug development, recently made the decision to lay off employees following a merger with Exscientia. This move comes...
news-09112024-221219

Biotech Analyst and CEO Discuss Election Results: Insights from Brian Skorney and Daphne Zohar

Biotech analyst Brian Skorney and biotech executive Daphne Zohar recently appeared on "The Readout LOUD" podcast to share their thoughts on how the outcomes of the recent election may impact the biotech industry. They...
news-15112024-041829

Understanding Generalized Pustular Psoriasis in Adults: Symptoms, Treatments, and Images

Generalized Pustular Psoriasis (GPP) is a skin condition that can affect individuals of any age, but it is most commonly seen in middle-aged adults, with a higher prevalence in women. The condition is characterized...
news-12112024-102000

Pharmalittle: GSK Leaves BIO, AbbVie Schizophrenia Drug Fails & More – Pharma News Update

Good morning, everyone, and welcome to a new week of work. We hope you had a restful weekend and are ready to dive back into the routine of online meetings and deadlines. Let's start...
transforming-radiology-the-rise-of-generative-a

Transforming Radiology: The Rise of Generative AI

Transforming Radiology: The Future of Generative AI In a room filled with radiologists at a conference in Chicago this week, a groundbreaking prediction was made: by 2030, generative AI will become an integral part of...